Search
Now showing items 1-10 of 11
Low Prevalence of VRE Gastrointestinal Colonization of Hospitalized Patients in Manitoba Tertiary Care and Community Hospitals
(2000-1-1)
OBJECTIVE: To determine the prevalence of vancomycin-resistant enterococci (VRE) bowel colonization in hospitalized patients in Manitoba who had stool specimens collected for Clostridium difficile toxin and/or culture ...
Mutant Prevention Concentrations of Doripenem and Meropenem Alone and in Combination with Colistin (Polymyxin E), Levofloxacin and Tobramycin in Pseudomonas aeruginosa
(2009-1-1)
BACKGROUND: With a limited number of available antimicrobial
agents to treat Pseudomonas aeruginosa infections, the prevention of
emergence of antimicrobial resistance and its subsequent spread is
critical. In the present ...
Antimicrobial Susceptibility of 6685 Organisms Isolated from Canadian Hospitals: CANWARD 2007
(2009-1-1)
BACKGROUND: Antimicrobial resistance is a growing problem in
North American hospitals as well as hospitals worldwide.
OBJECTIVES: To assess the antimicrobial susceptibility patterns of
commonly used agents against the 20 ...
Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2007)
(2009-1-1)
BACKGROUND: Canadian hospitals as well as hospitals worldwide
are increasingly faced with antibiotic-resistant pathogens, including
multidrug-resistant (MDR) strains.
OBJECTIVES: To assess the prevalence of pathogens, ...
Characterization of Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals: Results of the CANWARD 2007 Study
(2009-1-1)
INTRODUCTION: Pseudomonas aeruginosa is an important nosocomial
pathogen. The purpose of the present study was to evaluate the
antimicrobial susceptibility profile of P aeruginosa isolates obtained
from patients in different ...
Differences in Antimicrobial Susceptibility in Escherichia coli from Canadian Intensive Care Units Based on Regional and Demographic Variables
(2008-1-1)
OBJECTIVES: Escherichia coli resistance to antimicrobials varies according to many factors. E coli isolates from Canadian intensive care units (ICUs) were studied to determine the distribution and demographics associated ...
In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram-Positive and Gram-Negative Bacterial Pathogens Isolated from Patients in Canadian Hospitals in 2007
(2009-1-1)
BACKGROUND: In 2008, ceftobiprole was approved by Health
Canada for the treatment of patients with complicated skin and skin
structure infections including diabetic foot infections; approval of
ceftobiprole by the United ...
Antimicrobial-Resistant Streptococcus pneumoniae in Canadian Hospitals: Results from the 2007 CANWARD Study
(2009-1-1)
BACKGROUND: The Canadian Ward Surveillance Study
(CANWARD 2007) tested isolates collected from January to December
2007 from 12 Canadian hospitals to a range of antimicrobial agents.
The present paper focuses on antimicrobial ...
Analysis of 1560 Inpatient and Outpatient Escherichia coli Isolates from across Canada—Results from the CANWARD 2007 Study
(2009-1-1)
OBJECTIVES: Escherichia coli was the most common pathogen isolated
in the Canadian Ward Surveillance Study (CANWARD 2007)
and remains one of the most common pathogens isolated in all health
care settings. An in-depth ...
Characterization of Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci and Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (Can-Icu) Study (2005–2006)
(2008-1-1)
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and vancomycin-resistant enterococci (VRE) are important hospital pathogens in Canada and ...